Previous close | 5.80 |
Open | 5.80 |
Bid | 3.10 |
Ask | 7.30 |
Strike | 22.50 |
Expiry date | 2024-10-18 |
Day's range | 5.80 - 5.80 |
Contract range | N/A |
Volume | |
Open interest | 18 |
WALTHAM, Mass., May 31, 2024--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming investor conferences in June:
WALTHAM, Mass., May 10, 2024--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming investor conferences in May:
Viridian Therapeutics ( NASDAQ:VRDN ) First Quarter 2024 Results Key Financial Results Net loss: US$48.5m (loss...